`Case 1:17-cv-01407-CFC Document 300 Filed 03/13/19 Page 1 of 2 PagelD #: 26319
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF DELAWARE
`
`Consol. Civ. No. l7-l407-CFC
`
`GENENTECH, INC. and CITY OF )
`HOPE,
`
`) )
`
`) )
`
`) )
`
`) )
`
`ORDER
`
`Plaintiffs",
`
`V-
`
`AMGEN INC.
`
`Defendant,
`
`Whereas, Plaintiffs have moved the Court to amend the Protective Order (D.I.
`
`209) so that they may use discovery obtained in this litigation to initiate a new patent
`
`infringement action against Defendant based on a supplement
`
`to Defendant’s
`
`Biologics License Application No. 761028 (the “sBLA”) (see D.I. 291);
`
`Whereas, neither party attached the Protective Order to the filings they made
`
`in connection with Plaintiffs’ motion or discussed the language of the Protective
`
`Order during oral argument; and
`
`Whereas, Paragraph 28 of the Protective Order
`
`states: “Confidential
`
`Discovery Material produced by a Party
`
`may be used by a Receiving Party only
`
`for purposes of this Litigation orfitture United States patent infringement litigation
`
`
`
`Case 1:17-cv-01407-CFC Document 300 Filed 03/13/19 Page 2 of 2 PageID #: 26320
`Case 1:17-cv-01407-CFC Document 300 Filed 03/13/19 Page 2 of 2 PageID #: 26320
`
`between the Parties arisingfiom Defendant isfiling ofBiologz'cs License Application
`
`No. 761028” (D.I. 209 at 1] 28) (emphasis added);
`
`NOW, THEREFORE, at Wilmington this 13th day of March, 2019,
`
`it is
`
`HEREBY ORDERED that the parties shall submit on or before March 15, 2019 a
`
`letter, in fourteen-point font and no longer than 400 words, addressing the following
`
`question: In light of the above-quoted language from Paragraph 28 of the Protective
`
`Order, why is it necessary to amend the Protective Order in order for Plaintiffs to be
`
`able to initiate future patent litigation based on Defendant’s sBLA?
`
`92
`
`UNITED STATES DIST
`
`T JUDGE
`
`